External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer

We have previously developed and externally validated a prognostic model of overall survival (OS) in men with metastatic, castration-resistant prostate cancer (mCRPC) treated with docetaxel. We sought to externally validate this model in a broader group of men with docetaxel-naïve mCRPC and in speci...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical oncology 2023-05, Vol.41 (15), p.2736-2746
Hauptverfasser:	Halabi, Susan, Yang, Qian, Roy, Akash, Luo, Bin, Araujo, John C, Logothetis, Christopher, Sternberg, Cora N, Armstrong, Andrew J, Carducci, Michael A, Chi, Kim N, de Bono, Johann S, Petrylak, Daniel P, Fizazi, Karim, Higano, Celestia S, Morris, Michael J, Rathkopf, Dana E, Saad, Fred, Ryan, Charles J, Small, Eric J, Kelly, William Kevin
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Docetaxel - therapeutic use Humans Male ORIGINAL REPORTS Prognosis Proportional Hazards Models Prostatic Neoplasms, Castration-Resistant - pathology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!